STAAR Surgical Company STAA

Updated: 18 Jun 2026

NASDAQ | Technology | Medtech, implantable lenses

No signal published yet

We already track STAAR Surgical and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow STAAR Surgical free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Technology
Sector
Medtech, implantable lenses
We're already tracking STAAR Surgical Company — here are the latest events we've registered

Recent News

  • On June 18, 2026, the company announced that all proposals at its annual general meeting, including board elections and equity plan amendments, received majority approval. Earlier in May, the company reported record first-quarter net sales of $93.5 million, representing a year-over-year increase of nearly 120%. The company also recently surpassed the milestone of 4 million ICLs sold globally.

What Firelda Watch includes for STAAR Surgical Company

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of STAAR Surgical Company will be delivered in the same format.

Want to follow STAAR Surgical Company? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow STAAR Surgical free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

STAAR Surgical Company STAA
STAAR Surgical — follow and we'll monitor it
Follow STAAR Surgical free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.